Qiagen NV（QGEN）资讯与事件QGENQiagen NV

Qiagen Suspends Full-Year 2026 Outlook

Qiagen has suspended its full-year 2026 outlook given the announced transaction with EQT Private Equity while the transaction is pending. Qiagen will also not hold a conference call for its Q3 2026 results.

EQT XI Fund Offers €46.50 per Share for Qiagen

Qiagen (QGEN) and the EQT XI fund announced an agreement under which Crown NL Bidco B.V. announced its decision to make an all-cash voluntary public takeover offer for the acquisition of all outstanding Qiagen shares at EUR 46.50 per share. The bidder is a holding company indirectly controlled by EQT XI fund with further indirect participations held by co-investors Luxinva S.A. and CPP Investment Board Europe. EQT Private Equity is managed and controlled by affiliates of EQT AB (EQBBF) with registered seat in Stockholm, Sweden. The takeover offer follows a comprehensive review by Qiagen's supervisory board and managing board that assessed Qiagen's strategic prospects and included discussions with both strategic and financial parties. The Qiagen boards believe the transaction will provide the best environment for Qiagen's next growth phase, giving Qiagen greater flexibility to invest for the long term under private ownership while providing shareholders with attractive and certain cash value. The bidder will offer Qiagen shareholders EUR 46.50 in cash for each Qiagen share, which represents a premium of 40.3% to the XETRA closing price of EUR 33.15 per Qiagen share on July 8, the last trading day prior to the publication of market reports regarding takeover interest from private equity firms. The transaction values Qiagen at approximately EUR 10.8B in enterprise value, or approximately $12.1B at current exchange rates, including approximately $1.1B of net debt. Closing expected in mid-2027, subject to, inter alia, a minimum acceptance threshold of 50% of the outstanding share capital plus one Qiagen share and customary regulatory clearances.